COVID-19 in Pregnancy and Risk for Preeclampsia
Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study
As the COVID-19 pandemic continues to linger, more data are becoming available about what possible links there may be between COVID-19 infection in pregnancy and risks to mothers and their babies. In this study, research teams from around the world came together to study pregnant women with COVID-19 infection to ask what outcomes in mothers or their babies could be linked to COVID-19. Researchers found the risk for preeclampsia was 76% higher in a study group of 706 women who had COVID-19 during pregnancy (compared to a group of pregnant women without COVID-19 diagnosis). In a smaller analysis in their study of only pregnant women with COVID-19 infection but without any symptoms (i.e., asymptomatic), researchers still found a 63% increased risk for preeclampsia in the asymptomatic women. Researchers also found increased risks for severe infection and preterm birth in women with COVID-19 infection in pregnancy. Studies like these are important to understand how COVID-19 illness may affect pregnant women and can be taken into account when making decisions about social distancing, masking, and vaccination.
LINK: https://pubmed.ncbi.nlm.nih.gov/33885740/
About Research Roundup
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Related Articles
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Hypertensive disorders of pregnancy significantly increase your risk of developing long-term heart problems. A careful review of blood pressure elevations during and after pregnancy may assist in iden...
Hypertensive disorders of pregnancy (HDP) can affect different groups of women in different ways, and even though we know this happening, we don't fully understand why. There are many factors, like bi...
There is growing evidence that studies examining pregnancy and its complications need to start early within the pregnancy to fully understand the nature of preeclampsia. Key gestational milestones, wh...
It is known that chronic hypertension and high BMI (body mass index) are risk factors for hypertensive disorders of pregnancy (HDP). Studies documenting this risk have usually assessed blood pre...
Several biomarker tests are under development to predict or diagnose preeclampsia. While none of these tests are yet widely accepted in U.S. clinical practice, two FDA-approved tests are available in...